位置:首页 > 蛋白库 > ESPR_MYCTU
ESPR_MYCTU
ID   ESPR_MYCTU              Reviewed;         132 AA.
AC   P9WJB7; L0TDR1; P96228; Q8VIS2;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   03-AUG-2022, entry version 43.
DE   RecName: Full=Nucleoid-associated protein EspR {ECO:0000305};
DE   AltName: Full=ESX-1 transcriptional regulatory protein EspR {ECO:0000305};
GN   Name=espR; OrderedLocusNames=Rv3849;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [3]
RP   FUNCTION AS AN ACTIVATOR, INDUCTION, DOMAIN, AND DISRUPTION PHENOTYPE.
RX   PubMed=18685700; DOI=10.1038/nature07219;
RA   Raghavan S., Manzanillo P., Chan K., Dovey C., Cox J.S.;
RT   "Secreted transcription factor controls Mycobacterium tuberculosis
RT   virulence.";
RL   Nature 454:717-721(2008).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [5]
RP   FUNCTION IN REGULATION OF THE ESPACD OPERON.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=22389481; DOI=10.1128/jb.00142-12;
RA   Hunt D.M., Sweeney N.P., Mori L., Whalan R.H., Comas I., Norman L.,
RA   Cortes T., Arnvig K.B., Davis E.O., Stapleton M.R., Green J., Buxton R.S.;
RT   "Long-range transcriptional control of an operon necessary for virulence-
RT   critical ESX-1 secretion in Mycobacterium tuberculosis.";
RL   J. Bacteriol. 194:2307-2320(2012).
RN   [6]
RP   FUNCTION, DNA-BINDING, SUBCELLULAR LOCATION, AND INDUCTION.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=22479184; DOI=10.1371/journal.ppat.1002621;
RA   Blasco B., Chen J.M., Hartkoorn R., Sala C., Uplekar S., Rougemont J.,
RA   Pojer F., Cole S.T.;
RT   "Virulence regulator EspR of Mycobacterium tuberculosis is a nucleoid-
RT   associated protein.";
RL   PLoS Pathog. 8:E1002621-E1002621(2012).
RN   [7]
RP   FUNCTION, AND DNA-BINDING.
RC   STRAIN=ATCC 35801 / TMC 107 / Erdman;
RX   PubMed=23743602; DOI=10.1007/s00284-013-0404-8;
RA   Cao G., Howard S.T., Zhang P., Hou G., Pang X.;
RT   "Functional analysis of the EspR binding sites upstream of espR in
RT   Mycobacterium tuberculosis.";
RL   Curr. Microbiol. 67:572-579(2013).
RN   [8]
RP   MUTAGENESIS OF ARG-69; LYS-71; ARG-100; ARG-105; ASP-122; ARG-125 AND
RP   ASP-131.
RC   STRAIN=H37Rv;
RX   PubMed=24633871; DOI=10.1128/jb.00039-14;
RA   Blasco B., Japaridze A., Stenta M., Wicky B.I., Dietler G., Dal Peraro M.,
RA   Pojer F., Cole S.T.;
RT   "Functional dissection of intersubunit interactions in the EspR virulence
RT   regulator of Mycobacterium tuberculosis.";
RL   J. Bacteriol. 196:1889-1900(2014).
RN   [9]
RP   INDUCTION.
RC   STRAIN=ATCC 35801 / TMC 107 / Erdman;
RX   PubMed=25536998; DOI=10.1099/mic.0.000023;
RA   Cao G., Howard S.T., Zhang P., Wang X., Chen X.L., Samten B., Pang X.;
RT   "EspR, a regulator of the ESX-1 secretion system in Mycobacterium
RT   tuberculosis, is directly regulated by the two-component systems MprAB and
RT   PhoPR.";
RL   Microbiology 161:477-489(2015).
RN   [10]
RP   CRYSTALLIZATION.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21206031; DOI=10.1107/s174430911004618x;
RA   Gangwar S.P., Meena S.R., Saxena A.K.;
RT   "Cloning, purification, crystallization and preliminary X-ray analysis of
RT   ESX-1-secreted protein regulator (EspR) from Mycobacterium tuberculosis.";
RL   Acta Crystallogr. F 67:83-86(2011).
RN   [11] {ECO:0007744|PDB:3QF3, ECO:0007744|PDB:3QWG, ECO:0007744|PDB:3QYX}
RP   X-RAY CRYSTALLOGRAPHY (2.41 ANGSTROMS) OF 2-122, FUNCTION, DNA-BINDING,
RP   SUBUNIT, AND DOMAIN.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21883526; DOI=10.1111/j.1365-2958.2011.07813.x;
RA   Blasco B., Stenta M., Alonso-Sarduy L., Dietler G., Peraro M.D., Cole S.T.,
RA   Pojer F.;
RT   "Atypical DNA recognition mechanism used by the EspR virulence regulator of
RT   Mycobacterium tuberculosis.";
RL   Mol. Microbiol. 82:251-264(2011).
RN   [12] {ECO:0007744|PDB:3R1F}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), SUBUNIT, DOMAIN, AND DNA-BINDING.
RX   PubMed=21795602; DOI=10.1073/pnas.1110242108;
RA   Rosenberg O.S., Dovey C., Tempesta M., Robbins R.A., Finer-Moore J.S.,
RA   Stroud R.M., Cox J.S.;
RT   "EspR, a key regulator of Mycobacterium tuberculosis virulence, adopts a
RT   unique dimeric structure among helix-turn-helix proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:13450-13455(2011).
RN   [13] {ECO:0007744|PDB:4NDW}
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS).
RX   PubMed=24699733; DOI=10.1107/s2053230x14004166;
RA   Gangwar S.P., Meena S.R., Saxena A.K.;
RT   "Comparison of four different crystal forms of the Mycobacterium
RT   tuberculosis ESX-1 secreted protein regulator EspR.";
RL   Acta Crystallogr. F Struct. Biol. Commun. 70:433-437(2014).
CC   -!- FUNCTION: Virulence regulator that has both architectural and
CC       regulatory roles. Impacts cell wall functions and pathogenesis through
CC       regulation of multiple genes, including the espACD operon, which is a
CC       key ESX-1 component. Influences target gene expression positively or
CC       negatively, depending on its binding position relative to the genes it
CC       controls. Acts by binding directly to the DNA. May play a central role
CC       in regulating virulence gene expression. {ECO:0000269|PubMed:18685700,
CC       ECO:0000269|PubMed:21883526, ECO:0000269|PubMed:22389481,
CC       ECO:0000269|PubMed:22479184, ECO:0000269|PubMed:23743602}.
CC   -!- SUBUNIT: Homodimer. Binds DNA as a dimer of dimers.
CC       {ECO:0000269|PubMed:21795602, ECO:0000269|PubMed:21883526}.
CC   -!- INTERACTION:
CC       P9WJB7; P9WJB7: espR; NbExp=3; IntAct=EBI-15937970, EBI-15937970;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, nucleoid
CC       {ECO:0000269|PubMed:22479184}.
CC   -!- INDUCTION: Negatively autoregulated (PubMed:22479184).
CC       Transcriptionally regulated by the MprB/MprA and PhoP/PhoR two-
CC       component systems (PubMed:25536998). Expression is growth phase-
CC       dependent, peaking in the stationary phase (PubMed:22479184). Probably
CC       induced upon phagocytosis (PubMed:18685700).
CC       {ECO:0000269|PubMed:18685700, ECO:0000269|PubMed:22479184,
CC       ECO:0000269|PubMed:25536998}.
CC   -!- DOMAIN: The N-terminal domain binds DNA and the C-terminal domain is
CC       involved in dimerization. Both domains are required for transcriptional
CC       activity and for ESX-1 function. {ECO:0000269|PubMed:18685700,
CC       ECO:0000269|PubMed:21795602, ECO:0000269|PubMed:21883526}.
CC   -!- DISRUPTION PHENOTYPE: Mutants exhibit growth defect during infection of
CC       mice. They establish a stable infection by three weeks, but the
CC       bacterial burden is an order of magnitude less than the wild-type.
CC       {ECO:0000269|PubMed:18685700}.
CC   -!- CAUTION: Was originally thought to be secreted via the ESX-1 secretion
CC       system, but it was probably released in the medium via cell lysis.
CC       {ECO:0000305|PubMed:18685700, ECO:0000305|PubMed:22479184}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP46678.1; -; Genomic_DNA.
DR   PIR; F70654; F70654.
DR   RefSeq; NP_218366.1; NC_000962.3.
DR   RefSeq; WP_003399759.1; NZ_NVQJ01000057.1.
DR   PDB; 3QF3; X-ray; 2.41 A; A/B/C/D/E/F=2-132.
DR   PDB; 3QWG; X-ray; 1.99 A; A/B=2-122.
DR   PDB; 3QYX; X-ray; 3.75 A; A/B/C/D=2-132.
DR   PDB; 3R1F; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=1-132.
DR   PDB; 4NDW; X-ray; 3.30 A; A/B=1-132.
DR   PDBsum; 3QF3; -.
DR   PDBsum; 3QWG; -.
DR   PDBsum; 3QYX; -.
DR   PDBsum; 3R1F; -.
DR   PDBsum; 4NDW; -.
DR   AlphaFoldDB; P9WJB7; -.
DR   SMR; P9WJB7; -.
DR   STRING; 83332.Rv3849; -.
DR   PaxDb; P9WJB7; -.
DR   GeneID; 45427853; -.
DR   GeneID; 886184; -.
DR   KEGG; mtu:Rv3849; -.
DR   TubercuList; Rv3849; -.
DR   eggNOG; COG1476; Bacteria.
DR   OMA; PAYFYDA; -.
DR   Proteomes; UP000001584; Chromosome.
DR   CollecTF; EXPREG_00000c30; -.
DR   GO; GO:0005829; C:cytosol; IDA:MTBBASE.
DR   GO; GO:0005576; C:extracellular region; IDA:MTBBASE.
DR   GO; GO:0009295; C:nucleoid; IEA:UniProtKB-SubCell.
DR   GO; GO:0009274; C:peptidoglycan-based cell wall; HDA:MTBBASE.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0003677; F:DNA binding; IDA:MTBBASE.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0050708; P:regulation of protein secretion; IDA:MTBBASE.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:MTBBASE.
DR   GO; GO:0052572; P:response to host immune response; IEP:MTBBASE.
DR   Gene3D; 1.10.260.40; -; 1.
DR   InterPro; IPR001387; Cro/C1-type_HTH.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom_sf.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Cytoplasm; DNA-binding; Reference proteome;
KW   Repressor; Transcription; Transcription regulation; Virulence.
FT   CHAIN           1..132
FT                   /note="Nucleoid-associated protein EspR"
FT                   /id="PRO_0000393905"
FT   DNA_BIND        38..50
FT                   /note="H-T-H motif"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         69
FT                   /note="R->A: Affects protein stability. Decreases affinity
FT                   for DNA and dimerization capacity."
FT                   /evidence="ECO:0000269|PubMed:24633871"
FT   MUTAGEN         71
FT                   /note="K->A: Decreases affinity for DNA. Does not affect
FT                   dimerization."
FT                   /evidence="ECO:0000269|PubMed:24633871"
FT   MUTAGEN         100
FT                   /note="R->A: Affects protein stability. Decreases affinity
FT                   for DNA. Does not affect dimerization."
FT                   /evidence="ECO:0000269|PubMed:24633871"
FT   MUTAGEN         105
FT                   /note="R->A: Does not affect DNA binding."
FT                   /evidence="ECO:0000269|PubMed:24633871"
FT   MUTAGEN         122
FT                   /note="D->A: Moderate impact on protein stability. Does not
FT                   affect DNA binding."
FT                   /evidence="ECO:0000269|PubMed:24633871"
FT   MUTAGEN         125
FT                   /note="R->A: Moderate impact on protein stability. Does not
FT                   affect DNA binding."
FT                   /evidence="ECO:0000269|PubMed:24633871"
FT   MUTAGEN         131
FT                   /note="D->A: Moderate impact on protein stability. Does not
FT                   affect DNA binding."
FT                   /evidence="ECO:0000269|PubMed:24633871"
FT   HELIX           5..15
FT                   /evidence="ECO:0007829|PDB:3QWG"
FT   TURN            19..21
FT                   /evidence="ECO:0007829|PDB:3QWG"
FT   HELIX           26..35
FT                   /evidence="ECO:0007829|PDB:3QWG"
FT   HELIX           42..49
FT                   /evidence="ECO:0007829|PDB:3QWG"
FT   STRAND          51..53
FT                   /evidence="ECO:0007829|PDB:3QF3"
FT   HELIX           58..67
FT                   /evidence="ECO:0007829|PDB:3QWG"
FT   HELIX           73..76
FT                   /evidence="ECO:0007829|PDB:3QWG"
FT   HELIX           78..94
FT                   /evidence="ECO:0007829|PDB:3QWG"
FT   HELIX           97..106
FT                   /evidence="ECO:0007829|PDB:3QF3"
FT   HELIX           111..127
FT                   /evidence="ECO:0007829|PDB:3QF3"
SQ   SEQUENCE   132 AA;  14709 MW;  84EA0DB906D81996 CRC64;
     MSTTFAARLN RLFDTVYPPG RGPHTSAEVI AALKAEGITM SAPYLSQLRS GNRTNPSGAT
     MAALANFFRI KAAYFTDDEY YEKLDKELQW LCTMRDDGVR RIAQRAHGLP SAAQQKVLDR
     IDELRRAEGI DA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024